🚀 Announcing the launch of Phase 2 of the Biomarkers of Aging Challenge Series: Mortality Prediction! Phase 2 focuses on identifying and benchmarking the most promising predictors of mortality, aiming to advance our understanding and validation of aging biomarkers. This Phase will run until November 1, 2024. ☠️ Why Mortality Prediction? Mortality is a crucial outcome for aging biomarkers due to its clear and binary nature. Both first-generation biomarkers and newer models trained specifically to predict time to death have shown significant promise in predicting mortality and age-related diseases. Phase 2 benchmarks predictors of mortality to identify the current limits of accuracy and prediction, while also harnessing this potential to provide valuable insights and foster innovation in mortality prediction. 💰 Prize: $70,000 USD in rewards 👉 Join Phase 2: https://lnkd.in/eW957q8v 👈 🏆About The Biomarkers of Aging Challenge Series: Systematic benchmarking and validation of aging biomarkers are essential for their use in clinical research and longevity interventions. However, limited access to high-quality omics datasets and disparate biomarker implementations present significant challenges. The Biomarkers of Aging Consortium addresses these issues by hosting a series of challenges designed to drive innovation and collaboration. 🎯 Challenge Objectives: Our Challenge spans three phases, with the goal of identifying and benchmarking the best predictors of chronological age, mortality, and multi-morbidity. We aim to discover cutting-edge biomarkers that can reliably predict aging-related outcomes, supporting ongoing technology development and enabling large-scale longitudinal studies. 🙏 Many thanks to our partners for their support of the Challenge including: Methuselah Foundation, Alamar Biosciences, Inc., XPRIZE #Healthspan, Sage Bionetworks, Institute of Competition Sciences , VoLo Foundation 💗 We also want to thank all the fantastic competitors who have participated in our Challenge so far and those who will join us in this phase and beyond. Your dedication and innovative spirit are driving the future of longevity research. 🙌 Together, we can drive the future of biomarkers of aging, unlocking a better understanding of the aging process and making significant strides towards extending healthy human lifespan: https://lnkd.in/eW957q8v
Let's go 🚀
Physician | Longevity Consultant | Health Coach | Founder and CEO, Healthspan Coaching LLC | C-level | Online one-on-one longevity coaching | agingdoc.com
1wI’m thrilled to see the launch of Phase 2 of the Biomarkers of Aging Challenge Series, focusing on mortality prediction. This initiative addresses a vital need in the field by rigorously validating biomarkers, which is essential for realistic aging biology founded clinical trials, and the eventual approval of safe and effective confirmed gerotherapeutics. Incentivizing such groundbreaking work is crucial to bridging key barriers and advancing science, ultimately bringing innovative gerotherapeutics to patients. I look forward to the outcomes of this exciting phase!